2020-09918. National Cancer Institute; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Frederick National Laboratory Advisory Committee to the National Cancer Institute.

    The meeting will be held as a virtual meeting and open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (http://videocast.nih.gov/​).

    Name of Committee: Frederick National Laboratory Advisory Committee to the National Cancer Institute.

    Date: May 21, 2020.

    Time: 1:00 p.m. to 3:00 p.m.

    Agenda: Ongoing and new activities at the Frederick National Laboratory for Cancer Research.

    Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting).

    Contact Person: Caron A. Lyman, Ph.D., Executive Secretary, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 7W126, Bethesda, MD 20892-9750, 240-276-6348, lymanc@mail.nih.gov.

    Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

    Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/​advisory/​fac/​fac.htm,, where an agenda, instructions for access, and Start Printed Page 27422any additional information for the meeting will be posted when available.

    This notice is being published less than 15 days prior to the meeting due to scheduling difficulties.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: May 5, 2020.

    Melanie J. Pantoja,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2020-09918 Filed 5-7-20; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
05/08/2020
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2020-09918
Dates:
May 21, 2020.
Pages:
27421-27422 (2 pages)
PDF File:
2020-09918.pdf